Correlation Between Scpharmaceuticals and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Scopus Biopharma, you can compare the effects of market volatilities on Scpharmaceuticals and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Scopus Biopharma.
Diversification Opportunities for Scpharmaceuticals and Scopus Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Scpharmaceuticals and Scopus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Scopus Biopharma
If you would invest (100.00) in Scopus Biopharma on December 1, 2024 and sell it today you would earn a total of 100.00 from holding Scopus Biopharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Scpharmaceuticals vs. Scopus Biopharma
Performance |
Timeline |
Scpharmaceuticals |
Scopus Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Scpharmaceuticals and Scopus Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scpharmaceuticals and Scopus Biopharma
The main advantage of trading using opposite Scpharmaceuticals and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |